Understand the source comparison
Best Peptides for ACL Tear Recovery: Research Comparison
BPC-157 VEGF upregulation, angiogenesis, FAK-paxillin activation Proliferative (weeks 2–8) Rat MCL and Achilles models show 30–40% faster healing, improved tensile strength 10 mcg/kg daily, local or systemic Strongest preclinical support for ligament-to-bone i
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- VEGF upregulation, angiogenesis, FAK-paxillin activation
- Proliferative (weeks 2–8)
- Rat MCL and Achilles models show 30–40% faster healing, improved tensile strength
- 10 mcg/kg daily, local or systemic
- Strongest preclinical support for ligament-to-bone integration; no human RCTs
- TB-500 (Thymosin Beta-4)
- Actin binding, cell migration, anti-inflammatory (TNF-alpha, IL-6 downregulation)
- Inflammatory and proliferative (weeks 0–12)
- Equine tendon studies, dermal wound models; reduces fibrosis
- 2–10 mg subcutaneous, twice weekly
- Well-supported for reducing scar tissue; less specific ligament data than BPC-157
- GHK-Cu
- Copper cofactor for lysyl oxidase, collagen cross-linking, Type I collagen synthesis
- Remodeling (months 3–12)
- Dermal wound healing models show 70% increase in collagen production
- 1–3 mg daily, subcutaneous or topical at injury site
- Mechanistically sound for collagen maturation; limited ligament-specific research